Fuan Pharmaceutical (Group) Co., Ltd.

¥3.66As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300194Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.56%)
Div yield 1.91%
ROE 0.77%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM 139.3
TSR TTM (17.41%)
Mkt cap ¥4.354B
ROIC 1.63%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3.88
5.97%
(80.41%)
Hold 8|12|12|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.06
0.06
0.06
15.99%
27.11%
24.15%
14.89%
Revenue¥M
213.7
221.9
220.8
219.7
9.66%
8.86%
6.36%
4.63%
Peers (US$652.7M)
Cap (US$)
PE
669.6M
3.849x
Capital
TTM
5Y
10Y
Leveragex
2.822
(0.033)
(0.025)
EBIT/Intx
1.846
0.509
0.542
Own earn%
(42.98)
153.50
112.16
Sh yield%
58.55
11.55
10.69
Owners
Insiders/Inst%
3.37
65.56
Short interest%
2.62
SBC / revenue%
2.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
11–21
$1 testx
−0.1
Incr. ROIC%
19